SS-31 (Elamipretide): Mitochondrial Protection, Cardiolipin Stabilization, and Cellular Energy Restoration
A New Frontier in Mitochondrial Medicine Mitochondria regulate cellular energy, stress responses, redox balance, and metabolic flexibility. As these systems decline with age or metabolic stress, mitochondrial dysfunction becomes a driver of fatigue, impaired tissue repair, and systemic metabolic decline. SS31, also known as Elamipretide or MTP131, is a mitochondriatargeted tetrapeptide designed to selectively target the inner mitochondrial membrane and interact with cardiolipin. By stabilizing mitochondrial structure and reducing oxidative stress, SS31 has become a leading research tool for studying mitochondrial restoration. What Is SS31? SS31 is a synthetic mitochondriatargeted tetrapeptide with the sequence DArgDmtLysPheNH₂. It can: • Cross mitochondrial membranes • Concentrate at the inner mitochondrial membrane • Bind electrostatically to cardiolipin • Support mitochondrial architecture and ATP production Unlike general antioxidants, SS31 modulates ROS production at the source while preserving physiological signaling. Mechanism of Action 1. Cardiolipin Stabilization SS31 binds directly to cardiolipin, helping maintain membrane curvature, respiratory chain structure, and ATP synthesis efficiency. 2. Reduced ROS Production By stabilizing membrane architecture, SS31 reduces “electron leak” that generates excess ROS. This improves redox balance while maintaining physiological signaling. 3. Enhanced ATP Generation With more efficient electron flow, SS31 supports improved mitochondrial energy output and muscular performance. 4. Protection Against Mitochondrial Stress SS31 has been evaluated in models of ischemiareperfusion injury, agerelated decline, metabolic syndrome, and mitochondrial diseases. Research Highlights 1. Muscle Function and Fatigue Improves skeletal muscle endurance, mitochondrial respiration, and ATP turnover. 2. Cardiac Performance Supports healthier mitochondrial morphology, reduces oxidative stress, and improves cardiac output in research settings. 3. AgeRelated Mitochondrial Decline Reverses cardiolipin oxidation, restores respiratory chain stability, and enhances endurance in aging models. 4. Mitochondrial Disorders Improves mitochondrial structure and oxygen utilization in studies of mitochondrial pathology. Cellular Pathways Overview SS31 (Elamipretide): Mitochondrial Protection, Cardiolipin Stabilization, and Cellular Energy Restoration – research illustration Synergistic Combinations (Research Context) • MOTSc — enhances mitochondrial signaling and AMPK activation • 5Amino1MQ — improves NAD⁺ availability and metabolic pathways • NAD⁺ precursors — support sirtuin activity and mitochondrial energy • Glutathione — reinforces redox balance during mitochondrial output Research Use and Safety SS31 has undergone extensive preclinical and early clinical evaluation. Key points: • Generally welltolerated in research environments • Effects are most pronounced under mitochondrial stress • Not approved for clinical or consumer use All descriptions refer strictly to laboratory and researchonly contexts. Summary SS31 represents a shift in mitochondrial science toward targeted membrane stabilization. By binding cardiolipin, reducing electron leak, and supporting ATP generation, SS31 restores a fundamental layer of cellular energy production. Its effects on muscle function, cardiac resilience, and agerelated mitochondrial decline position SS31 as a central molecule in metabolic and longevity research. References (Selection) 1. Birk AV, et al. J Am Soc Nephrol. (2013). 2. Szeto HH. Pharmacology & Therapeutics. (2014). 3. Zhao K, et al. J Biol Chem. (2004). 4. Kloner RA, et al. Circulation. (2015). 5. Dai DF, et al. Aging Cell. (2017). Educational & Research Disclaimer This content is for educational and research purposes only. No medical advice or product claims are implied. Compounds discussed are not approved for human or clinical use and are intended for invitro laboratory research only. ———————— FAQ: What is SS31 (Elamipretide) in research? SS31 is a mitochondriatargeted tetrapeptide studied for promoting mitochondrial protection, stabilizing cardiolipin, and supporting cellular energy output in preclinical models. How does SS31 interact with mitochondria in studies? Research shows SS31 localizes to the inner mitochondrial membrane, where it binds cardiolipin and may help reduce oxidative stress and improve electron transport efficiency. Is SS31 considered a therapeutic compound? No. SS31 from The Peptide Company is intended strictly for laboratory and invitro research use and is not approved for human, medical, or clinical use. What research applications involve SS31? SS31 is explored in cell and animal models examining mitochondrial dysfunction, bioenergetics, oxidative stress, membrane stability, and agingrelated metabolic decline. Does SS31 improve ATP production in studies? Some preclinical work suggests SS31 may improve mitochondrial coupling efficiency and ATP output, though these findings
For research use only. Not for human consumption.